Which of the following statements is NOT true regarding the limits on Schedule II prescriptive authority for mid-level practitioners in some states?
Mid-level practitioners must discuss the condition with any patient who is given a controlled substance at least once per month with the collaborating physician
Mid-level practitioners may prescribe no more than a 30-day supply of a Schedule II controlled substance
Mid-level practitioners may continue a Schedule II prescription for more than 30 days only after prior approval from the collaborating physician
Mid-level practitioners may be delegated prescriptive authority for more than 5 oral dosage forms of a Schedule II controlled substance
Mid-level practitioners may be delegated prescriptive authority for more than 5 oral dosage forms of a Schedule II controlled substance
Rationale: Regarding limits on Schedule II prescriptive authority for mid-level practitioners in some states, it is not true that they may be delegated prescriptive authority for more than 5 oral dosage forms of a Schedule II controlled substance. It is true that these practitioners must discuss conditions with patients taking controlled substances, that no more than a 30-day supply can be prescribed, and that such prescriptions can be continued for more than 30 days once approved by the collaborating physician.
You might also like to view...
Which of the following is not an example of verbal communication?
A. Use of language B. Use of words C. Use of body language D. None of the above
____ is an inflammation of the myocardial tissue.
A. Pulmonary edema B. Myocarditis C. Stenosis D. Hemoptysis
Developer contains hydroquinone and elon
Indicate whether the statement is true or false
What is the name of the condition that involves plaque or clots escaping from the femoral or iliac veins?
a. deep vein thrombosis b. carotid stenosis c. atherosclerosis d. claudication